熱門資訊> 正文

Nkarta，Nuvation Bio，冠状动脉的增长

2024-03-25 22:00

Gainers: Landos Biopharma (LABP) +176%.
Altamira Therapeutics (CYTO) +86%.
Nkarta (NKTX) +22%.
Flora Growth (FLGC) +21%.
Sagimet Biosciences (SGMT) +19%.
Losers: Nuvation Bio (NUVB) -23%.
Autonomix Medical (AMIX) -14%.
Leafly Holdings (LFLY) -12%.
Invivyd (IVVD) -12%.
Canopy Growth (CGC) -10%.
S&P 500 Health Care Sector +0.1% to $1,699.17. Health Care Equipment & Services +0.2% to $2,262.08. Pharmaceuticals, Biotechnology & Life Science which contributes 58% to index is +0.5% to $1,105.36.

More on Health Care Select Sector SPDR

XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance
Healthcare In 2024: Navigating The Biopharma Bull Run
Johnson & Johnson, Boston Scientific least shorted stocks in S&P 500 healthcare sector for Feb-end
Waters, Moderna most shorted stocks in S&P 500 health sector till Jan-end

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。